Nyumbani › Limfoma ya Selu Kubwa za B Diffuse › Ohio › Cincinnati
Majaribio ya kliniki ya Limfoma ya Selu Kubwa za B Diffuse katika Cincinnati, OH
Masomo 11 ya Limfoma ya Selu Kubwa za B Diffuse yanatafuta washiriki katika vituo vya Cincinnati na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
InaajiriHatua 2
- Oncology Hematology Care - Kenwood, Cincinnati
- University of Cincinnati Medical Center, Cincinnati
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
InaajiriUtafiti wa uchunguzi
- Cincinnati Children's Hospital Medical Center, Cincinnati
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
InaajiriHatua 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · Mi 15 mbali
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
InaajiriHatua 3
- Oncology_Hematology Care Clinical Trials, LLC (OHC) ( Site 8002), Cincinnati
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
InaajiriHatua 2/3
- Saint Elizabeth Medical Center Edgewood ( Site 0165), Edgewood · Mi 8 mbali
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
InaajiriHatua 2
- University of Cincinnati Medical Center ( Site 0156), Cincinnati
- Saint Elizabeth Medical Center Edgewood ( Site 0141), Edgewood · Mi 8 mbali
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
InaajiriHatua 1/2
- University of Cincinnati (UC) Physicians Company, LLC, Cincinnati
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
InaajiriHatua 3
- Oncology Hematology Care Clinical Trials, Cincinnati
- University of Cincinnati, Cincinnati
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
InaajiriHatua 1
- University of Cincinnati Medical Center, Cincinnati
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
InaajiriHatua 1
- University of Cincinnati, Cincinnati
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
InaajiriHatua 1/2
- University of Cincinnati, Cincinnati
Majaribio ya Limfoma ya Selu Kubwa za B Diffuse katika miji mingine
- New York City, NYUtafiti 21
- Baldwin Park, CAUtafiti 19
- Chicago, ILUtafiti 18
- Houston, TXUtafiti 17
- Los Angeles, CAUtafiti 17
- Boston, MAUtafiti 16
- Milwaukee, WIUtafiti 16
- Nashville, TNUtafiti 15
- Portland, ORUtafiti 15
- Philadelphia, PAUtafiti 15
- Durham, NCUtafiti 14
- Dallas, TXUtafiti 13
Masomo mengine katika Cincinnati
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 35
- Saratani (aina zote)Utafiti 27
- Saratani ya MatitiUtafiti 25
- Kushindwa kwa MoyoUtafiti 24
- Kansari ya kolorektaliUtafiti 21
- Leukemia ya Myeloid ya GhaflaUtafiti 20
- Saratani ya MetastasiUtafiti 20
- Kansari ya MayaiUtafiti 19
- Saratan ya MapafuUtafiti 19
- UnenepuUtafiti 19
- Saratani ya ProstateUtafiti 18
- Multiple MyelomaUtafiti 17
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.